Universe Pharmaceuticals INC (UPC) SEC Filings — 2024

Filings

• Universe Pharmaceuticals Sells 388,000 Shares — 6-K · Dec 12, 2024
• Universe Pharmaceuticals Announces Share Consolidation — 6-K · Nov 13, 2024
• Universe Pharmaceuticals Gets Nasdaq Bid Price Warning — 6-K · Nov 1, 2024
• Universe Pharmaceuticals Appoints New Auditor — 6-K · Oct 10, 2024
• Universe Pharmaceuticals Holds 2024 Annual Meeting, Approves Proposals — 6-K · Sep 27, 2024
• Universe Pharmaceuticals Files 6-K Report — 6-K · Sep 20, 2024
• Universe Pharmaceuticals Files 6-K for August 2024 AGM — 6-K · Sep 3, 2024
• Universe Pharmaceuticals Closes Public Offering — 6-K · Jul 18, 2024
• Universe Pharma Transfers to Nasdaq Capital Market, Avoids Delisting — 6-K · Feb 7, 2024
• Universe Pharmaceuticals INC Files Annual Report on Form 20-F — 20-F · Jan 30, 2024